Marc Lipsitch

Marc Lipsitch

Harvard University

H-index: 128

North America-United States

About Marc Lipsitch

Marc Lipsitch, With an exceptional h-index of 128 and a recent h-index of 86 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Epidemiology, Infectious Diseases, Surveillance, Microbiology, Biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparison of the test-negative design and cohort design with explicit target trial emulation for evaluating COVID-19 vaccine effectiveness

Estimating epidemiological delay distributions for infectious diseases

Optimal environmental testing frequency for outbreak surveillance

Examining bias from differential depletion of susceptibles in vaccine effectiveness estimates in settings of waning

What’s next: using infectious disease mathematical modelling to address health disparities

Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection

Estimated excess deaths due to COVID-19 among the urban population of Mainland China, December 2022 to January 2023

Diagnostics for Public Health—Infectious Disease Surveillance and Control

Marc Lipsitch Information

University

Position

Department of Epidemiology

Citations(all)

63865

Citations(since 2020)

37440

Cited By

39944

hIndex(all)

128

hIndex(since 2020)

86

i10Index(all)

388

i10Index(since 2020)

325

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Marc Lipsitch Skills & Research Interests

Epidemiology

Infectious Diseases

Surveillance

Microbiology

Biostatistics

Top articles of Marc Lipsitch

Title

Journal

Author(s)

Publication Date

Comparison of the test-negative design and cohort design with explicit target trial emulation for evaluating COVID-19 vaccine effectiveness

Epidemiology

Guilin Li

Hanna Gerlovin

Michael J Figueroa Muñiz

Jessica K Wise

Arin L Madenci

...

2024/3/1

Estimating epidemiological delay distributions for infectious diseases

medRxiv

Sang Woo Park

Andrei R Akhmetzhanov

Kelly Charniga

Anne Cori

Nicholas G Davies

...

2024

Optimal environmental testing frequency for outbreak surveillance

Epidemics

Jason W Olejarz

Kirstin I Oliveira Roster

Stephen M Kissler

Marc Lipsitch

Yonatan H Grad

2024/2/15

Examining bias from differential depletion of susceptibles in vaccine effectiveness estimates in settings of waning

American Journal of Epidemiology

Rebecca Kahn

Daniel R Feikin

Ryan E Wiegand

Marc Lipsitch

2024/1

What’s next: using infectious disease mathematical modelling to address health disparities

International Journal of Epidemiology

Danielle M Richard

Marc Lipsitch

2024/2/1

Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection

medRxiv

Qifang Bi

Barbra A Dickerman

Huong Q McLean

Emily T Martin

Manjusha Gaglani

...

2023/9/27

Estimated excess deaths due to COVID-19 among the urban population of Mainland China, December 2022 to January 2023

Epidemiology

Leon Raphson

Marc Lipsitch

2024/1/29

Diagnostics for Public Health—Infectious Disease Surveillance and Control

Marc Lipsitch

Yonatan Grad

2024/4/23

Prospective Evaluation of Machine Learning for Public Health Screening: Identifying Unknown Hepatitis C Carriers

NEJM AI

Noa Dagan

Ori Magen

Michael Leshchinsky

Maya Makov-Assif

Marc Lipsitch

...

2024/1/25

Public role in research oversight

Journal of virology

Marc Lipsitch

Thomas V Inglesby

Anita Cicero

David A Relman

2024/3/13

JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data

Vaccine

Jennifer B Rosen

Robert J Arciuolo

Preeti Pathela

Christopher B Boyer

Jennifer Baumgartner

...

2024/1/25

Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States

European Journal of Epidemiology

Katherine M Jia

William P Hanage

Marc Lipsitch

Amelia G Johnson

Avnika B Amin

...

2023/11

Defining and emulating target trials of the effects of postexposure vaccination using observational data

medrxiv

Christopher Boyer

Marc Lipsitch

2023/5/5

What can be learned from viral co-detection studies in human populations

medRxiv

Taylor Chin

Ellen F Foxman

Timothy A Watkins

Marc Lipsitch

2023

Some principles for using epidemiologic study results to parameterize transmission models

medRxiv

Keya Joshi

Rebecca Kahn

Christopher Boyer

Marc Lipsitch

2023/10/3

Learning from covid-19 to improve surveillance for emerging threats

Daniel B Jernigan

Dylan George

Marc Lipsitch

2023/5

Geographic targeting of COVID-19 testing to maximize detection in Los Angeles County

Open Forum Infectious Diseases

Katherine M Jia

Rebecca Kahn

Rebecca Fisher

Sharon Balter

Marc Lipsitch

2023/7

Prediction of post-PCV13 pneumococcal evolution using invasive disease data enhanced by inverse-invasiveness weighting

medRxiv

Xueting Qiu

Lesley McGee

Laura L Hammitt

Lindsay R Grant

Katherine L O’Brien

...

2023/12/11

Mass drug administration of azithromycin: an analysis

Rebecca Kahn

Nir Eyal

Samba O Sow

Marc Lipsitch

2023/3/1

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant

Joseph A Lewnard

Vennis Hong

Jeniffer S Kim

Sally F Shaw

Bruno Lewin

...

2023

See List of Professors in Marc Lipsitch University(Harvard University)

Co-Authors

H-index: 127
Miguel Hernan

Miguel Hernan

Harvard University

H-index: 93
Christophe Fraser

Christophe Fraser

University of Oxford

H-index: 81
William Hanage

William Hanage

Harvard University

H-index: 80
Bruce R. Levin

Bruce R. Levin

Emory & Henry College

H-index: 64
Ted Cohen

Ted Cohen

Yale University

academic-engine